These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 9774339

  • 1. Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network.
    Tzahar E, Moyer JD, Waterman H, Barbacci EG, Bao J, Levkowitz G, Shelly M, Strano S, Pinkas-Kramarski R, Pierce JH, Andrews GC, Yarden Y.
    EMBO J; 1998 Oct 15; 17(20):5948-63. PubMed ID: 9774339
    [Abstract] [Full Text] [Related]

  • 2. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
    Pinkas-Kramarski R, Lenferink AE, Bacus SS, Lyass L, van de Poll ML, Klapper LN, Tzahar E, Sela M, van Zoelen EJ, Yarden Y.
    Oncogene; 1998 Mar 12; 16(10):1249-58. PubMed ID: 9546426
    [Abstract] [Full Text] [Related]

  • 3. Bivalence of EGF-like ligands drives the ErbB signaling network.
    Tzahar E, Pinkas-Kramarski R, Moyer JD, Klapper LN, Alroy I, Levkowitz G, Shelly M, Henis S, Eisenstein M, Ratzkin BJ, Sela M, Andrews GC, Yarden Y.
    EMBO J; 1997 Aug 15; 16(16):4938-50. PubMed ID: 9305636
    [Abstract] [Full Text] [Related]

  • 4. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.
    Pinkas-Kramarski R, Soussan L, Waterman H, Levkowitz G, Alroy I, Klapper L, Lavi S, Seger R, Ratzkin BJ, Sela M, Yarden Y.
    EMBO J; 1996 May 15; 15(10):2452-67. PubMed ID: 8665853
    [Abstract] [Full Text] [Related]

  • 5. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4.
    Komurasaki T, Toyoda H, Uchida D, Morimoto S.
    Oncogene; 1997 Dec 04; 15(23):2841-8. PubMed ID: 9419975
    [Abstract] [Full Text] [Related]

  • 6. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
    Alimandi M, Wang LM, Bottaro D, Lee CC, Kuo A, Frankel M, Fedi P, Tang C, Lippman M, Pierce JH.
    EMBO J; 1997 Sep 15; 16(18):5608-17. PubMed ID: 9312020
    [Abstract] [Full Text] [Related]

  • 7. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.
    Karunagaran D, Tzahar E, Beerli RR, Chen X, Graus-Porta D, Ratzkin BJ, Seger R, Hynes NE, Yarden Y.
    EMBO J; 1996 Jan 15; 15(2):254-64. PubMed ID: 8617201
    [Abstract] [Full Text] [Related]

  • 8. Feedback inhibition by RALT controls signal output by the ErbB network.
    Anastasi S, Fiorentino L, Fiorini M, Fraioli R, Sala G, Castellani L, Alemà S, Alimandi M, Segatto O.
    Oncogene; 2003 Jul 03; 22(27):4221-34. PubMed ID: 12833145
    [Abstract] [Full Text] [Related]

  • 9. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
    Motoyama AB, Hynes NE, Lane HA.
    Cancer Res; 2002 Jun 01; 62(11):3151-8. PubMed ID: 12036928
    [Abstract] [Full Text] [Related]

  • 10. Differential heat stress stability of epidermal growth factor receptor and erbB-2 receptor tyrosine kinase activities.
    Liu SM, Carpenter G.
    J Cell Physiol; 1993 Nov 01; 157(2):237-42. PubMed ID: 7901224
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of a conditionally active v-ErbB and an EGF-R inhibitor on transformation of NIH-3T3 cells and abrogation of cytokine dependency of hematopoietic cells.
    McCubrey JA, Shelton JG, Steelman LS, Franklin RA, Sreevalsan T, McMahon M.
    Oncogene; 2004 Oct 14; 23(47):7810-20. PubMed ID: 15361836
    [Abstract] [Full Text] [Related]

  • 13. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas.
    Alimandi M, Romano A, Curia MC, Muraro R, Fedi P, Aaronson SA, Di Fiore PP, Kraus MH.
    Oncogene; 1995 May 04; 10(9):1813-21. PubMed ID: 7538656
    [Abstract] [Full Text] [Related]

  • 14. The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies.
    Dougall WC, Qian X, Peterson NC, Miller MJ, Samanta A, Greene MI.
    Oncogene; 1994 Aug 04; 9(8):2109-23. PubMed ID: 7913542
    [Abstract] [Full Text] [Related]

  • 15. Signal transduction and oncogenesis by ErbB/HER receptors.
    Marmor MD, Skaria KB, Yarden Y.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):903-13. PubMed ID: 14967450
    [Abstract] [Full Text] [Related]

  • 16. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling.
    Graus-Porta D, Beerli RR, Daly JM, Hynes NE.
    EMBO J; 1997 Apr 01; 16(7):1647-55. PubMed ID: 9130710
    [Abstract] [Full Text] [Related]

  • 17. Epidermal growth factor receptor (EGFR) signaling in cancer.
    Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F, Salomon DS.
    Gene; 2006 Jan 17; 366(1):2-16. PubMed ID: 16377102
    [Abstract] [Full Text] [Related]

  • 18. Interaction between erbB-receptors and heregulin in breast cancer tumor progression and drug resistance.
    Lupu R, Cardillo M, Harris L, Hijazi M, Rosenberg K.
    Semin Cancer Biol; 1995 Jun 17; 6(3):135-45. PubMed ID: 7495981
    [Abstract] [Full Text] [Related]

  • 19. ErbB kinases and NDF signaling in human prostate cancer cells.
    Grasso AW, Wen D, Miller CM, Rhim JS, Pretlow TG, Kung HJ.
    Oncogene; 1997 Nov 27; 15(22):2705-16. PubMed ID: 9400997
    [Abstract] [Full Text] [Related]

  • 20. Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors.
    Sanderson MP, Dempsey PJ, Dunbar AJ.
    Growth Factors; 2006 Jun 27; 24(2):121-36. PubMed ID: 16801132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.